Your browser doesn't support javascript.
loading
PGBD5 promotes site-specific oncogenic mutations in human tumors.
Henssen, Anton G; Koche, Richard; Zhuang, Jiali; Jiang, Eileen; Reed, Casie; Eisenberg, Amy; Still, Eric; MacArthur, Ian C; Rodríguez-Fos, Elias; Gonzalez, Santiago; Puiggròs, Montserrat; Blackford, Andrew N; Mason, Christopher E; de Stanchina, Elisa; Gönen, Mithat; Emde, Anne-Katrin; Shah, Minita; Arora, Kanika; Reeves, Catherine; Socci, Nicholas D; Perlman, Elizabeth; Antonescu, Cristina R; Roberts, Charles W M; Steen, Hanno; Mullen, Elizabeth; Jackson, Stephen P; Torrents, David; Weng, Zhiping; Armstrong, Scott A; Kentsis, Alex.
Afiliação
  • Henssen AG; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Koche R; Cancer Biology &Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Zhuang J; Program in Bioinformatics and Integrative Biology, Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
  • Jiang E; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Reed C; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Eisenberg A; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Still E; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • MacArthur IC; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Rodríguez-Fos E; Joint BSC-CRG-IRB Research Program in Computational Biology, Barcelona Supercomputing Center (BSC-CNS), Barcelona, Spain.
  • Gonzalez S; Joint BSC-CRG-IRB Research Program in Computational Biology, Barcelona Supercomputing Center (BSC-CNS), Barcelona, Spain.
  • Puiggròs M; Joint BSC-CRG-IRB Research Program in Computational Biology, Barcelona Supercomputing Center (BSC-CNS), Barcelona, Spain.
  • Blackford AN; The Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge, UK.
  • Mason CE; Institute for Computational Biomedicine, Weill Cornell Medical College, New York, New York, USA.
  • de Stanchina E; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Gönen M; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Emde AK; New York Genome Center, New York, New York, USA.
  • Shah M; New York Genome Center, New York, New York, USA.
  • Arora K; New York Genome Center, New York, New York, USA.
  • Reeves C; New York Genome Center, New York, New York, USA.
  • Socci ND; Bioinformatics Core, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Perlman E; Northwestern University Feinberg School of Medicine, Ann &Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
  • Antonescu CR; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Roberts CWM; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Steen H; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Mullen E; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Jackson SP; The Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge, UK.
  • Torrents D; Department of Biochemistry, University of Cambridge, Cambridge, UK.
  • Weng Z; The Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.
  • Armstrong SA; Joint BSC-CRG-IRB Research Program in Computational Biology, Barcelona Supercomputing Center (BSC-CNS), Barcelona, Spain.
  • Kentsis A; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
Nat Genet ; 49(7): 1005-1014, 2017 Jul.
Article em En | MEDLINE | ID: mdl-28504702
ABSTRACT
Genomic rearrangements are a hallmark of human cancers. Here, we identify the piggyBac transposable element derived 5 (PGBD5) gene as encoding an active DNA transposase expressed in the majority of childhood solid tumors, including lethal rhabdoid tumors. Using assembly-based whole-genome DNA sequencing, we found previously undefined genomic rearrangements in human rhabdoid tumors. These rearrangements involved PGBD5-specific signal (PSS) sequences at their breakpoints and recurrently inactivated tumor-suppressor genes. PGBD5 was physically associated with genomic PSS sequences that were also sufficient to mediate PGBD5-induced DNA rearrangements in rhabdoid tumor cells. Ectopic expression of PGBD5 in primary immortalized human cells was sufficient to promote cell transformation in vivo. This activity required specific catalytic residues in the PGBD5 transposase domain as well as end-joining DNA repair and induced structural rearrangements with PSS breakpoints. These results define PGBD5 as an oncogenic mutator and provide a plausible mechanism for site-specific DNA rearrangements in childhood and adult solid tumors.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transformação Celular Neoplásica / Tumor Rabdoide / Transposases Limite: Adult / Animals / Child / Child, preschool / Humans / Infant Idioma: En Revista: Nat Genet Assunto da revista: GENETICA MEDICA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transformação Celular Neoplásica / Tumor Rabdoide / Transposases Limite: Adult / Animals / Child / Child, preschool / Humans / Infant Idioma: En Revista: Nat Genet Assunto da revista: GENETICA MEDICA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos